The impact of 2016 guideline on clinical practice for the management of hospital-acquired and ventilator-associated pneumonia in Taiwan Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018
Community-acquired pneumonia as an emergency: time for an aggressive intervention to lower mortality Source: Eur Respir J 2011; 38: 253-260 Year: 2011
The cost of inpatient care in community-acquired pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 258s Year: 2005
Challenges in the management of hospital-acquired pneumonia including ventilator-associated pneumonia Source: ERS Course 2018 - Respiratory Infections Year: 2018
Mortality during hospitalisation for pneumonia in Alberta, Canada, is associated with physician volume Source: Eur Respir J 2003; 22: 148-155 Year: 2003
Determinants of hospital costs in community acquired pneumonia Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens Year: 2012
The impact of a stewardship programme on outcomes in patients admitted with community-acquired pneumonia Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections Year: 2020
Implementation of ERS guidelines for the management of adult community-acquired pneumonia in a primary care hospital Source: Eur Respir J 2001; 18: Suppl. 33, 503s Year: 2001
Risk factors analysis influenced occurrence of ventilator-associated pneumonia in surgical intensive care unit Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010
Prognostic factors of the patients admitted to intensive care unit with nursing and healthcare-associated pneumonia Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015
Ventilator-associated pneumonia: outcomes of 91 patients in a teaching Brazilian hospital Source: Eur Respir J 2003; 22: Suppl. 45, 451s Year: 2003
Epidemiology, antimicrobial resistance and clinical outcomes in nursing home associated pneumonia compared to community acquired pneumonia Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013
Cost minimization for community-acquired pneumonia management in Belarussian hospital from implementation of clinical guidelines Source: Eur Respir J 2005; 26: Suppl. 49, 258s Year: 2005
Guideline-concordant therapy and outcomes in healthcare-associated pneumonia Source: Eur Respir J 2011; 38: 878-887 Year: 2011
Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia Source: Eur Respir J 2011; 37: 1332-1339 Year: 2011
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia Source: Guideline 2017 Year: 2017
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia Source: Eur Respir J, 50 (3) 1700582; 10.1183/13993003.00582-2017 Year: 2017
A population-based study of the costs of care for community-acquired pneumonia Source: Eur Respir J 2004; 23: 610-616 Year: 2004
Community accuired pneumonia and direct hospital cost Source: Eur Respir J 2006; 28: Suppl. 50, 376s Year: 2006